Jerrold Rosenbaum, director of Massachusetts General Hospital’s Center for the Neuroscience of Psychedelics, discusses the potential of using psychedelics, such as MDMA and magic mushrooms, to treat treatment-resistant mood disorders like depression and anxiety. Topics include the effect of psychedelics on the brain, how psychedelic therapy is conducted, the legality of medicinal psychedelics, and current research findings.